Compile Data Set for Download or QSAR
maximum 50k data
Found 90 Enz. Inhib. hit(s) with all data for entry = 7175
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179558(US9126980, 3)
Affinity DataIC50:  90.4nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179558(US9126980, 3)
Affinity DataIC50:  127nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179566(US9126980, 11)
Affinity DataIC50:  253nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179580(US9126980, 25)
Affinity DataIC50:  255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179597(US9126980, 42)
Affinity DataIC50:  255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179590(US9126980, 35)
Affinity DataIC50:  257nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179593(US9126980, 38)
Affinity DataIC50:  269nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179597(US9126980, 42)
Affinity DataIC50:  270nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179590(US9126980, 35)
Affinity DataIC50:  272nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179600(US9126980, 45)
Affinity DataIC50:  293nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179557(US9126980, 2)
Affinity DataIC50:  295nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179566(US9126980, 11)
Affinity DataIC50:  296nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179583(US9126980, 28)
Affinity DataIC50:  311nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179582(US9126980, 27)
Affinity DataIC50:  315nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179593(US9126980, 38)
Affinity DataIC50:  328nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179581(US9126980, 26)
Affinity DataIC50:  370nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179557(US9126980, 2)
Affinity DataIC50:  377nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179560(US9126980, 5)
Affinity DataIC50:  412nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179580(US9126980, 25)
Affinity DataIC50:  427nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179583(US9126980, 28)
Affinity DataIC50:  448nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179582(US9126980, 27)
Affinity DataIC50:  454nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179573(US9126980, 18)
Affinity DataIC50:  457nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179561(US9126980, 6)
Affinity DataIC50:  465nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179579(US9126980, 24)
Affinity DataIC50:  466nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179562(US9126980, 7)
Affinity DataIC50:  474nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179601(US9126980, 46)
Affinity DataIC50:  475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179571(US9126980, 16)
Affinity DataIC50:  475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179600(US9126980, 45)
Affinity DataIC50:  480nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179581(US9126980, 26)
Affinity DataIC50:  494nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179587(US9126980, 32)
Affinity DataIC50:  512nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179556(US9126980, 1)
Affinity DataIC50:  519nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179599(US9126980, 44)
Affinity DataIC50:  522nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179584(US9126980, 29)
Affinity DataIC50:  529nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179596(US9126980, 41)
Affinity DataIC50:  531nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179569(US9126980, 14)
Affinity DataIC50:  559nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179595(US9126980, 40)
Affinity DataIC50:  562nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179561(US9126980, 6)
Affinity DataIC50:  563nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179594(US9126980, 39)
Affinity DataIC50:  566nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179573(US9126980, 18)
Affinity DataIC50:  585nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179560(US9126980, 5)
Affinity DataIC50:  609nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179587(US9126980, 32)
Affinity DataIC50:  631nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179594(US9126980, 39)
Affinity DataIC50:  632nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179562(US9126980, 7)
Affinity DataIC50:  638nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179571(US9126980, 16)
Affinity DataIC50:  640nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179589(US9126980, 34)
Affinity DataIC50:  641nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179579(US9126980, 24)
Affinity DataIC50:  652nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179596(US9126980, 41)
Affinity DataIC50:  660nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179563(US9126980, 8)
Affinity DataIC50:  664nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179601(US9126980, 46)
Affinity DataIC50:  666nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM179595(US9126980, 40)
Affinity DataIC50:  673nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: